| Microbes in lung cancer initiation, treatment, and outcome: boon or bane? H Guo, L Zhao, J Zhu, P Chen, H Wang, M Jiang, X Liu, H Sun, W Zhao, ... Seminars in Cancer Biology 86, 1190-1206, 2022 | 23 | 2022 |
| DNA damage response and repair gene alterations increase tumor mutational burden and promote poor prognosis of advanced lung cancer J Dai, M Jiang, K He, H Wang, P Chen, H Guo, W Zhao, H Lu, Y He, ... Frontiers in oncology 11, 708294, 2021 | 21 | 2021 |
| Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse H Guo, L Diao, X Zhou, JN Chen, Y Zhou, Q Fang, Y He, R Dziadziuszko, ... Translational Lung Cancer Research 10 (6), 2452, 2021 | 16 | 2021 |
| A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio J Gao, Y Ren, H Guo, R Mao, H Xie, H Su, Y She, J Deng, M Yang, B Han, ... Annals of Translational Medicine 8 (7), 2020 | 16 | 2020 |
| Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC Y He, L Chen, L Zhao, S Dang, G Liu, S Sasada, PC Ma, N Van Zandwijk, ... Theranostics 11 (14), 7092, 2021 | 14 | 2021 |
| Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a narrative review X Ying, N Ma, X Zhang, H Guo, Y Liu, B Chen, S Zhao, S Wu, W Li, ... Annals of palliative medicine 10 (4), 4806822-4804822, 2021 | 11 | 2021 |
| Immune checkpoints OX40 and OX40L in small-cell lung cancer: predict prognosis and modulate immune microenvironment P Chen, H Wang, L Zhao, H Guo, L Zhang, W Zhang, C Sun, S Zhao, W Li, ... Frontiers in Oncology 11, 713853, 2021 | 10 | 2021 |
| The application of artificial intelligence in lung cancer: a narrative review H Zhang, D Meng, S Cai, H Guo, P Chen, Z Zheng, J Zhu, W Zhao, ... Translational Cancer Research 10 (5), 2478, 2021 | 10 | 2021 |
| Mechanisms of progression and heterogeneity in multiple nodules of lung adenocarcinoma Y He, X Liu, H Wang, L Wu, M Jiang, H Guo, J Zhu, S Wu, H Sun, S Chen, ... Small Methods 5 (6), 2100082, 2021 | 9 | 2021 |
| Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer R Han, H Guo, J Shi, H Wang, S Zhao, Y Jia, X Liu, J Li, L Cheng, C Zhao, ... European Journal of Cancer 189, 112919, 2023 | 8 | 2023 |
| An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC) H Guo, B Li, L Diao, H Wang, P Chen, M Jiang, L Zhao, Y He, C Zhou Oncoimmunology 10 (1), 1947665, 2021 | 8 | 2021 |
| Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19 H Guo, X Chen, C Su, Y Liu, H Wang, C Sun, P Chen, M Jiang, Y Xu, ... Translational lung cancer research 9 (2), 337, 2020 | 8 | 2020 |
| Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study F Zhou, H Guo, X Zhou, H Xie, T Tian, W Zhao, G Gao, A Xiong, L Wang, ... Therapeutic Advances in Medical Oncology 14, 17588359221136759, 2022 | 7 | 2022 |
| Bridging the gap between outputs: domain adaptation for lung cancer IHC segmentation L Diao, H Guo, Y Zhou, Y He 2021 IEEE International Conference on Image Processing (ICIP), 6-10, 2021 | 7 | 2021 |
| Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment L Zhu, P Chen, H Wang, L Zhao, H Guo, M Jiang, S Zhao, W Li, J Zhu, ... Translational Cancer Research 11 (2), 339, 2022 | 6 | 2022 |
| Aberrant methylation modifications reflect specific drug responses in small cell lung cancer P Chen, H Guo, Y Liu, B Chen, S Zhao, S Wu, W Li, L Wang, K Jia, ... Genomics 113 (3), 1114-1126, 2021 | 6 | 2021 |
| Single-cell sequencing, an advanced technology in Lung Cancer Research H Wang, D Meng, H Guo, C Sun, P Chen, M Jiang, Y Xu, J Yu, Q Fang, ... OncoTargets and therapy, 1895-1909, 2021 | 6 | 2021 |
| Combinational immunotherapy based on immune checkpoints inhibitors in small cell lung cancer: is this the beginning to reverse the refractory situation? CZ Haoyue Guo, Yayi He, Peixin Chen, Lei Wang, Wei Li, Bin Chen, Yu Liu, Hao ... Journal of Thoracic Disease 12 (10), 2020 | 6 | 2020 |
| YAP1 expression is associated with survival and immunosuppression in small cell lung cancer P Chen, C Sun, H Wang, W Zhao, Y Wu, H Guo, C Zhou, Y He Cell Death & Disease 14 (9), 636, 2023 | 5 | 2023 |
| Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review Y Cai, B Wang, B Li, X Huang, H Guo, Y Liu, B Chen, S Zhao, S Wu, W Li, ... Annals of Translational Medicine 9 (11), 2021 | 5 | 2021 |
